Subscribe To
Alibaba split: ‘if you control the data, you control the business,' tematica research cio say
Tematica Research Chief Investment Officer Christopher Versace joins Yahoo Finance Live to discuss the tech sector, investor sentiment, the Fed's poli...
March 28, 2023, 10:00 am
Ionis (ions) posts new upbeat data from amyloidosis drug study
Ionis (IONS) reports positive long-term phase III study data, supporting the benefits of eplontersen as a treatment for hereditary transthyretin-media...
March 27, 2023, 12:59 pm
Carnival's ship will come in eventually
The leading cruise line's recovery is delayed amid a mountain of debt, but it has a path to profitabili...
March 27, 2023, 12:45 pm
Biomx to host fourth quarter and full year 2022 financial results conference call and webcast on march 29th, 2023
CAMBRIDGE, Mass. and NESS ZIONA, Israel, March 27, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a cli...
March 27, 2023, 7:00 am
Is viking therapeutics a smart buy on the dip?
Shares of Viking Therapeutics fell 25.2% during the week that ended March 24. Viking Pharmaceuticals fell in sympathy with Adaptimmune, which is devel...
March 27, 2023, 5:47 am
Nuscale power: is nrc certification of small module nuclear reactor enough?
NuScale's Small Module Reactor ("SMR") reached a major milestone in January when its design achieved certification from the Nuclear Regulatory Commiss...
March 27, 2023, 5:45 am
Uup: expect u.s. dollar rally on safe haven status
The UUP ETF gives investors exposure to the U.S. dollar relative to a basket of 6 global currencies. There are two possible future paths for the U.S. ...
March 26, 2023, 4:16 am
Uipath: it has the potential to have a very deep moat
The fall in UiPath's share price suggests that the company is reasonably valued in terms of its potential. Despite a challenging environment in 2022, ...
March 25, 2023, 5:36 am
Bio-path holdings to announce fourth quarter and full year 2022 financial results on march 31, 2023
HOUSTON, March 24, 2023 (GLOBE NEWSWIRE) -- Bio-path Holdings, Inc. (NASDAQ: BPTH), a biotechnology com...
March 24, 2023, 4:01 pm
Aurinia pharmaceuticals: all in on lupkynis - a tough bet
LUPKYNIS has had a lengthy and ultimately productive development pathway. Aurinia has gone all hands on deck to provide LUPKYNIS a successful launch....
March 24, 2023, 12:53 am
An advisor's guide to collar strategies
Persistent volatility over the last 12 months has been largely driven by investor uncertainty as to the path <...
March 23, 2023, 12:31 pm
Are business services stocks lagging api group (apg) this year?
Here is how APi (APG) and Uipath (PATH) have performed compared to their sector so far this year....
March 23, 2023, 11:27 am
Should you buy carvana (cvna) on the possibility of a rebound?
While Carvana (CVNA) seems to be pivoting on a better path, it still has lots to prove. Unless the company shows continued tangible progress on meetin...
March 23, 2023, 11:27 am
Infosys: delivering value while helping other companies succeed
Infosys, the second largest Indian company by market capitalization, is an IT consulting company that assists companies from different fields in their...
March 23, 2023, 5:56 am
Seeking income within equities: nationwide's interchangeable etfs
Economic uncertainty continues to equate to market uncertainty this year as advisors and investors weigh constantly evolving economic data and what it...
March 22, 2023, 7:44 pm
Uipath (path) just flashed golden cross signal: do you buy?
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?...
March 22, 2023, 11:29 am
Here's what is driving amgen (amgn) stock's outperformance
Amgen's (AMGN) key drugs like Prolia, Repatha and Otezla are driving sales. It is also rapidly advancing its robust pipeline....
March 22, 2023, 6:53 am
Farfetch: much stronger business than you may think
Farfetch's share price plummeted because investors were scared by its underperformance and delayed profitability path. Our analysis shows that underpe...
March 21, 2023, 3:31 pm
Why uipath (path) might be well poised for a surge
Uipath (PATH) shares have started gaining and might continue moving higher in the near term, as indicat...
March 21, 2023, 1:46 pm
Rubis: on track in a volatile environment
Rubis reported overall robust volumes and income numbers and double-digit bottom line earnings growth, although it was adjusted due to FX issues and a...
March 21, 2023, 12:22 pm